Loading...
Loading...

Go to the content (press return)

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

Author
Negredo, E.; Molto, J.; Puig, J.; Cinquegrana, D.; Bonjoch, A.; Perez, N.; López-Blázquez, R.; Blanco, A.; Clotet, B.; Rey-Joly, C.
Type of activity
Journal article
Journal
AIDS
Date of publication
2006-11
Volume
20
Number
17
First page
2159
Last page
2164
DOI
https://doi.org/10.1097/01.aids.0000247573.95880.db Open in new window
URL
https://www.ncbi.nlm.nih.gov/pubmed/17086055 Open in new window
Abstract
To assess the efficacy, safety, and pharmacokinetic interactions of ezetimibe in HIV-infected patients with poorly controlled antiretroviral-associated dyslipidaemia while taking pravastatin alone.
Group of research
GRBIO - Biostatistics and Bioinformatics Research Group

Participants

  • Negredo Puigmal, Eugènia  (author)
  • Molto Marhuenda, Jose  (author)
  • Puig, Jordi  (author)
  • Cinquegrana, D  (author)
  • Bonjoch Badia, Anna  (author)
  • Perez Alvarez, Nuria  (author)
  • López Blázquez, Raquel  (author)
  • Blanco, A  (author)
  • Clotet Sala, Bonaventura  (author)
  • Rey-Joly Barroso, Celestino  (author)